Clinical Trial Update: Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor [Phase 2]

View source ↗

Summary

Phase 2 trial comparing capecitabine with dacarbazine vs capecitabine with temozolomide in advanced/metastatic gastrointestinal, pancreatic, and esophageal neur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumors

Drugs mentioned

• Capecitabine + Dacarbazine
• Capecitabine + Temozolomide

Snippet

Sponsor: Peking University | Conditions: Neuroendocrine Tumors | Phase 2 | Status: UNKNOWN